← FDA Drug Approvals (Drugs@FDA)
TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOURRTS LABS · Approved 2024-08-13
Drug application
- FDA Application #
ANDA217606- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TADALAFIL
- Generic name
- TADALAFIL
- Active ingredients
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- FOURRTS LABS
- Manufacturer
- FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED
- First approval
- 2024-08-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown